Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 89

1.

Behavioural pharmacology of 5-HT3 receptor ligands.

Barnes JM, Barnes NM, Cooper SJ.

Neurosci Biobehav Rev. 1992 Spring;16(1):107-13. Review.

PMID:
1553101
2.

Serotonin and psychiatric disorders. A key to new therapeutic approaches.

Costall B, Naylor RJ.

Arzneimittelforschung. 1992 Feb;42(2A):246-9. Review.

PMID:
1586395
3.

The psychopharmacology of 5-HT3 receptors.

Costall B, Naylor RJ, Tyers MB.

Pharmacol Ther. 1990;47(2):181-202. Review.

PMID:
2203069
4.

5-HT3 and 5-HT4 receptors in terminal regions of the mesolimbic system.

Kilpatrick GJ, Hagan RM, Gale JD.

Behav Brain Res. 1996;73(1-2):11-3. Review.

PMID:
8788470
5.

Astra Award Lecture. The psychopharmacology of 5-HT3 receptors.

Costall B, Naylor RJ.

Pharmacol Toxicol. 1992 Dec;71(6):401-15. Review.

PMID:
1362267
6.
7.

Serotonin receptors as potential targets for modulation of nicotine use and dependence.

Fletcher PJ, Lê AD, Higgins GA.

Prog Brain Res. 2008;172:361-83. doi: 10.1016/S0079-6123(08)00918-7. Review.

PMID:
18772042
8.

Ventral tegmental area 5-HT receptors: mesolimbic dopamine release and behavioural studies.

Mylecharane EJ.

Behav Brain Res. 1996;73(1-2):1-5. Review.

PMID:
8788468
9.

Anxiolytic potential of 5-HT3 receptor antagonists.

Costall B, Naylor RJ.

Pharmacol Toxicol. 1992 Mar;70(3):157-62. Review.

PMID:
1349746
10.

Preclinical and clinical pharmacology of the 5-HT3 receptor antagonists.

Wolf H.

Scand J Rheumatol Suppl. 2000;113:37-45. Review.

PMID:
11028830
11.

Pharmacological properties and functions of central 5-HT3 receptors.

Costall B, Naylor RJ.

Therapie. 1991 Nov-Dec;46(6):437-44. Review.

PMID:
1840228
12.

The role of 5-HT3 receptors in drug dependence.

Grant KA.

Drug Alcohol Depend. 1995 May;38(2):155-71. Review.

PMID:
7671767
13.

Activation of mesolimbic dopamine function by phencyclidine is enhanced by 5-HT(2C/2B) receptor antagonists: neurochemical and behavioural studies.

Hutson PH, Barton CL, Jay M, Blurton P, Burkamp F, Clarkson R, Bristow LJ.

Neuropharmacology. 2000 Sep;39(12):2318-28.

PMID:
10974315
14.

Serotonergic mechanisms in anxiety.

Eison AS, Eison MS.

Prog Neuropsychopharmacol Biol Psychiatry. 1994 Jan;18(1):47-62. Review.

PMID:
8115673
15.

Current experience with 5-HT3 receptor antagonists in fibromyalgia.

Späth M.

Rheum Dis Clin North Am. 2002 May;28(2):319-28. Review.

PMID:
12122920
16.

5-HT3 receptors and the neural actions of alcohols: an increasingly exciting topic.

Lovinger DM.

Neurochem Int. 1999 Aug;35(2):125-30. Review.

PMID:
10405996
17.

Behavioral studies of serotonin receptor agonists as antidepressant drugs.

Lucki I.

J Clin Psychiatry. 1991 Dec;52 Suppl:24-31. Review.

PMID:
1684363
18.

Modulation of the A10 dopamine system: electrophysiological studies of the role of 5-HT3-like receptors.

Wang RY, Ashby CR Jr, Zhang JY.

Behav Brain Res. 1996;73(1-2):7-10. Review.

PMID:
8788469
19.

Behavioural pharmacology of 5-HT3 receptor antagonists: a critical update on therapeutic potential.

Greenshaw AJ.

Trends Pharmacol Sci. 1993 Jul;14(7):265-70. Review.

PMID:
8105596
20.

The classification of 5-hydroxytryptamine receptors.

Mylecharane EJ.

Clin Exp Pharmacol Physiol. 1989 Jun;16(6):517-22. Review.

PMID:
2670359

Supplemental Content

Support Center